Inventor · disambiguated record
Stephen Wright
Also filed as: WRIGHT STEPHEN · WRIGHT STEPHEN B · WRIGHT STEPHEN E
50 granted patents·28 pending applications·1,682 citations·filing 1986–2025
99Inventor score
Files withGW RES LTD35GW PHARMA LTD26JAZZ PHARMACEUTICALS RESEARCH UK LTD6COMPASS PATHFINDER LTD3WRIGHT STEPHEN E2
Top patents by PatentIndex Score
78 records- 0198US12427160B2Use of cannabinoids in the treatment of epilepsyJAZZ PHARMACEUTICALS RESEARCH UK LTD·Filed 2025·Granted Sep 30, 2025·1 cites·29 claims
- 0298US12064399B2Use of cannabinoids in the treatment of epilepsyJAZZ PHARMACEUTICALS RESEARCH UK LTD·Filed 2022·Granted Aug 20, 2024·14 cites·28 claims
- 0398US11963937B2Use of cannabinoids in the treatment of epilepsyGW RES LTD·Filed 2023·Granted Apr 23, 2024·14 cites·29 claims
- 0498US11766411B2Use of cannabinoids in the treatment of epilepsyGW RES LTD·Filed 2022·Granted Sep 26, 2023·17 cites·26 claims
- 0598US11701330B2Use of cannabinoids in the treatment of epilepsyGW RES LTD·Filed 2021·Granted Jul 18, 2023·19 cites·30 claims
- 0698US11633369B2Use of cannabinoids in the treatment of epilepsyGW RES LTD·Filed 2022·Granted Apr 25, 2023·26 cites·32 claims
- 0798US11446258B2Use of cannabinoids in the treatment of epilepsyGW RES LTD·Filed 2021·Granted Sep 20, 2022·30 cites·29 claims
- 0898US11357741B2Use of cannabinoids in the treatment of epilepsyGW RES LTD·Filed 2020·Granted Jun 14, 2022·33 cites·28 claims
- 0998US11311498B2Use of cannabinoids in the treatment of epilepsyGW PHARMA LTD·Filed 2015·Granted Apr 26, 2022·34 cites·21 claims
- 1098US11154517B2Use of cannabinoids in the treatment of epilepsyGW RES LTD·Filed 2021·Granted Oct 26, 2021·38 cites·26 claims
- 1198US11154516B2Use of cannabinoids in the treatment of epilepsyGW RES LTD·Filed 2020·Granted Oct 26, 2021·42 cites·30 claims
- 1298US11096905B2Use of cannabinoids in the treatment of epilepsyGW RES LTD·Filed 2021·Granted Aug 24, 2021·43 cites·33 claims
- 1398US10966939B2Use of cannabinoids in the treatment of epilepsyGW RES LTD·Filed 2020·Granted Apr 6, 2021·47 cites·21 claims
- 1498US10849860B2Use of cannabinoids in the treatment of epilepsyGW RES LTD·Filed 2018·Granted Dec 1, 2020·49 cites·32 claims
- 1598US10765643B2Use of cannabidiol in the treatment of epilepsyGW PHARMA LTD·Filed 2015·Granted Sep 8, 2020·35 cites·15 claims
- 1698US10709671B2Use of cannabinoids in the treatment of epilepsyGW RES LTD·Filed 2016·Granted Jul 14, 2020·52 cites·24 claims
- 1798US10709674B2Use of cannabinoids in the treatment of epilepsyGW RES LTD·Filed 2019·Granted Jul 14, 2020·50 cites·20 claims
- 1898US10603288B2Use of cannabinoids in the treatment of epilepsyGW RES LTD·Filed 2018·Granted Mar 31, 2020·49 cites·28 claims
- 1998US10137095B2Use of cannabinoids in the treatment of epilepsyGW PHARMA LTD·Filed 2017·Granted Nov 27, 2018·63 cites·8 claims
- 2098US10111840B2Use of cannabinoids in the treatment of epilepsyGW PHARMA LTD·Filed 2015·Granted Oct 30, 2018·67 cites·14 claims
- 2198US10092525B2Use of cannabinoids in the treatment of epilepsyGW PHARMA LTD·Filed 2017·Granted Oct 9, 2018·62 cites·8 claims
- 2298US9956185B2Use of cannabinoids in the treatment of epilepsyGW PHARMA LTD·Filed 2017·Granted May 1, 2018·71 cites·11 claims
- 2398US9956186B2Use of cannabinoids in the treatment of epilepsyGW PHARMA LTD·Filed 2017·Granted May 1, 2018·68 cites·11 claims
- 2498US9956183B2Use of cannabinoids in the treatment of epilepsyGW PHARMA LTD·Filed 2017·Granted May 1, 2018·69 cites·18 claims
- 2598US9956184B2Use of cannabinoids in the treatment of epilepsyGW PHARMA LTD·Filed 2017·Granted May 1, 2018·67 cites·12 claims
- 2698US9949937B2Use of cannabinoids in the treatment of epilepsyGW PHARMA LTD·Filed 2017·Granted Apr 24, 2018·64 cites·14 claims
- 2798US9522123B2Use of one or a combination of phyto-cannabinoids in the treatment of epilepsyGW PHARMA LTD·Filed 2014·Granted Dec 20, 2016·62 cites·13 claims
- 2897US12318356B2Use of cannabinoids in the treatment of epilepsyJAZZ PHARMACEUTICALS RESEARCH UK LTD·Filed 2023·Granted Jun 3, 2025·2 cites·26 claims
- 2997US11400055B2Use of cannabidiol in the treatment of epilepsyGW RES LTD·Filed 2021·Granted Aug 2, 2022·29 cites·17 claims
- 3097US11065209B2Use of cannabidiol in the treatment of epilepsyGW RES LTD·Filed 2021·Granted Jul 20, 2021·43 cites·22 claims
- 3197US10918608B2Use of cannabidiol in the treatment of epilepsyGW RES LTD·Filed 2015·Granted Feb 16, 2021·50 cites·25 claims
- 3296US10583096B2Use of cannabinoids in the treatment of epilepsyGW RES LTD·Filed 2017·Granted Mar 10, 2020·35 cites·19 claims
- 3396US9949936B2Use of cannabinoids in the treatment of epilepsyGW PHARMA LTD·Filed 2016·Granted Apr 24, 2018·54 cites·14 claims
- 3496US9474726B2Use of cannabinoids in the treatment of epilepsyGW PHARMA LTD·Filed 2015·Granted Oct 25, 2016·74 cites·8 claims
- 3596US9066920B2Use of one or a combination of phyto-cannabinoids in the treatment of epilepsyWHALLEY BEN·Filed 2010·Granted Jun 30, 2015·74 cites·13 claims
- 3695US11679087B2Use of cannabinoids in the treatment of Angelman syndromeGW RES LTD·Filed 2017·Granted Jun 20, 2023·18 cites·19 claims
- 3795US11564935B2Method for treating anxiety disorders, headache disorders, and eating disorders with psilocybinCOMPASS PATHFINDER LTD·Filed 2021·Granted Jan 31, 2023·9 cites·27 claims
- 3894US11865126B2Method for treating anxiety disorders, headache disorders, and eating disorders with psilocybinCOMPASS PATHFINDER LTD·Filed 2023·Granted Jan 9, 2024·5 cites·30 claims
- 3994US11738035B2Method for treating anxiety disorders, headache disorders, and eating disorders with psilocybinCOMPASS PATHFINDER LTD·Filed 2022·Granted Aug 29, 2023·6 cites·29 claims
- 4093US11000486B2Combination of cannabinoids in the treatment of leukaemiaGW RES LTD·Filed 2018·Granted May 11, 2021·16 cites·18 claims
- 4191US10653641B2Use of cannabinoids in the treatment of mental disordersGW PHARMA LTD·Filed 2016·Granted May 19, 2020·15 cites·7 claims
- 4291US2024165048A1Use of cannabinoids in the treatment of epilepsyGW RES LTD·Filed 2023·Application pending·0 cites
- 4391US2025345349A1Cannabinoids in the treatment of epilepsyJAZZ PHARMACEUTICAL RES UK LIMITED·Filed 2025·Application pending·0 cites
- 4490US8790719B2Phytocannabinoids in the treatment of cancerPAROLARO DANIELA·Filed 2011·Granted Jul 29, 2014·43 cites·1 claims
- 4589US12161607B2Combination of cannabinoids in the treatment of leukemiaJAZZ PHARMACEUTICALS RESEARCH UK LTD·Filed 2021·Granted Dec 10, 2024·2 cites·16 claims
- 4689US9675654B2Phytocannabinoids in the treatment of cancerGW PHARMA LTD·Filed 2014·Granted Jun 13, 2017·17 cites·1 claims
- 4784US2022202738A1Cannabinoids in the treatment of epilepsyGW RES LTD·Filed 2022·Application pending·0 cites
- 4884US2024350428A1Use of cannabinoids in the treatment of epilepsyJAZZ PHARMACEUTICALS RESEACH UK LTD·Filed 2024·Application pending·0 cites
- 4983US2025387418A1Use of cannabinoids in the treatment of epilepsyJAZZ PHARMACEUTICALS RESEARCH UK LTD·Filed 2025·Application pending·0 cites
- 5080US2024261234A1Use of cannabidiol in the treatment of nocturnal snoringGW RES LTD·Filed 2023·Application pending·0 cites
Showing the top 50 of 78 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Stephen Wright files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →